4531 Sakura Tissue Tek Aj Alphen Aan Den Rijn The Netherlands

Lab Reagents

Human IgG antibody Laboratories manufactures the 4531 sakura tissue tek aj alphen aan den rijn the netherlands reagents distributed by Genprice. The 4531 Sakura Tissue Tek Aj Alphen Aan Den Rijn The Netherlands reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact sakura tissue tek. Other 4531 products are available in stock. Specificity: 4531 Category: Sakura Group: Tissue Tek

Tissue Tek information

TEK Rabbit pAb

A0743-50ul 50 ul
EUR 223

Anti-TEK antibody

STJ25807 100 µl
EUR 277
Description: This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.

Anti-TEK antibody

STJ29302 100 µl
EUR 277
Description: This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.

Anti-TEK Antibody

STJ503257 100 µg
EUR 476

Anti-TEK Antibody

STJ503258 100 µg
EUR 476

TEK Rabbit pAb

A7222-100ul 100 ul
EUR 308

TEK Rabbit pAb

A7222-200ul 200 ul
EUR 459

TEK Rabbit pAb

A7222-20ul 20 ul
EUR 183

TEK Rabbit pAb

A7222-50ul 50 ul
EUR 223

TEK Conjugated Antibody

C37274 100ul
EUR 397

Endoglin, murine recombinant

4531-10
EUR 398

Endoglin, murine recombinant

4531-100
EUR 2594

KHK antibody

10R-4531 100 ul
EUR 691
Description: Mouse monoclonal KHK antibody

SIL1 Blocking Peptide

33R-4531 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIL1 antibody, catalog no. 70R-6272

Otospiralin antibody

70R-4531 50 ug
EUR 467
Description: Rabbit polyclonal Otospiralin antibody raised against the N terminal of OTOS

LGI1 Antibody

4531-002mg 0.02 mg
EUR 171.82
Description: LGI1 Antibody: The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist, but the top band seen in the western blot is likely to be non-specific. This LGI1 antibody is predicted to be specific to LGI1 and not recognize other LGI proteins.

LGI1 Antibody

4531-01mg 0.1 mg
EUR 436.42
Description: LGI1 Antibody: The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist, but the top band seen in the western blot is likely to be non-specific. This LGI1 antibody is predicted to be specific to LGI1 and not recognize other LGI proteins.
Scroll to Top